Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SAPROPTERIN DIHYDROCHLORIDE
- BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
- A Randomized Controlled Phase II Clinical Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis
- A Phase I Clinical Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury
- The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
- Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
- Kuvan®'s Effect on the Cognition of Children With Phenylketonuria
- Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria
- Kuvan in People With Schizophrenia and Schizoaffective Disorder
- Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
- Liver Cell Transplant for Phenylketonuria
- Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
- Endothelial Facilitation in Alzheimer's Disease
- Study of Kuvan Treatment in Adults With GTPCH Deficiency
- Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria
- Phenylketonuria, Oxidative Stress, and BH4
- Kuvan® in Phenylketonuria Patients Less Than 4 Years Old
- Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
- Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.
- Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
- Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
- Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy
- The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
- Open-Label Extension Study of Kuvan for Autism
- Trial of Kuvan in Lesch-Nyhan Disease
- Sapropterin as a Treatment for Autistic Disorder
- Behavioral Effects of Kuvan in Children With Mild Phenylketonuria
- A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects
- Sapropterin in Individuals With Phenylketonuria
- Nutritional and Neurotransmitter Changes in PKU Subjects on BH4
- Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
- A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction
- Sapropterin Expanded Access Program
- A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease
- 6R-BH4 Pulmonary Arterial Hypertension Study
- A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
- A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension
- Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria
- Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels
Clinical trials list
click for details